TOURS, France—A new study published in the British Journal of Cancer found a dietary intake of 1.8g/d of algal DHA before and during chemotherapy made breast cancer cells more sensitive to anti-cancer drugs, boosting the effects of chemotherapy.
The study monitored and evaluated the health of breast cancer patients at the University Hospital Bretonneau. Algal DHA omega-3 supplementation began seven to 10 days before chemotherapy began and continued over the five-month chemotherapy treatment period. Tumor response rate, time to progression and overall survival were assessed. The authors found the most marked improvements in patients whose tumor cells had incorporated high levels of DHA.
